检索

期
标题
作者
卷 29, 编号 11/12 (2022)
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
PDF
(Rus)
卷 27, 编号 4 (2020)
Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs
Mkrtumyan A., Markova T.
PDF
(Rus)
编号 3 (2012)
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.
编号 4 (2018)
MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE
Demidov N., Antsiferov M.
PDF
(Rus)
编号 3 (2011)
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
编号 16 (2017)
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
PDF
(Rus)
编号 3 (2010)
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
编号 16 (2016)
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.
PDF
(Rus)
编号 3 (2009)
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M., Petraneva E., Anciferov M., Petraneva E.
编号 5 (2015)
Personalizirovannyy podkhod k rezhimu insulinoterapii - est' li mesto strakhu gipoglikemiy?
Volkova N., Porksheyan M.
PDF
(Rus)
编号 16 (2014)
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
PDF
(Rus)
编号 16 (2013)
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N., Ametov A., Antsiferov M.
PDF
(Rus)
卷 27, 编号 12 (2020)
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.
PDF
(Rus)
编号 16 (2012)
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M., Biryukova E., Zilov A.
PDF
(Rus)
1 - 14 的 14 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##